Trial Profile
Evaluation Of Regional Glucose Metabolism In Striatum As Measured By [18f]-Fluorodeoxyglucose Positron Emission Tomography Following Single Oral Dose Administration Of PF-02545920 In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2011
Price :
$35
*
At a glance
- Drugs Mardepodect (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 15 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 15 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.